Uganda

in page functions
[French]
Uganda
Total population (2018) 43,020,586
Birth cohort (2018) 1,775,183
Surviving Infants (surviving to 1 year per year, 2018) 1,676,567
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 38/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 55/1000
World Bank Index, IDA (2015) 3.74
Gross Nation Income (per capita US$, 2015) 700
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 116

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Uganda

Type of support

Approvals

2001-2023 (US$)
(28 Nov 2018)

Commitments

2001-2023 (US$)
(28 Nov 2018)

Disbursements

2000-2018 (US$)
(28 Nov 2018)

% Disbursed

(28 Nov 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $434,502,291 $485,028,791 $352,652,336
Cold Chain Equipment Optimisation Platform (CCEOP) $6,648,068 $6,648,068 $1,994,722 30%
Health system strengthening (HSS 1) $19,242,000 $19,242,000 $16,421,701 85%
Health system strengthening (HSS 2) $13,110,000 $30,600,000 $1,315,849 10%
HPV (NVS) $21,956,021 $27,404,521 $16,729,021 76%
Immunisation services support (ISS) $9,230,520 $9,230,520 $9,230,520 100%
Injection Safety Devices (NVS) $2,679,500 $3,369,000 $1,453,352 54%
Injection safety support (INS) $1,207,299 $1,207,299 $1,207,299 100%
IPV (NVS) $13,013,915 $13,013,915 $7,579,469 58%
Measles (NVS) $85,500 $85,500 $94,840 111%
Measles-Catch-up campaign (NVS) $109,500 $109,500 $124,301 114%
Meningitis A - campaign (NVS) $5,538,937 $5,538,937 $5,538,937 100%
Meningitis A - operational costs (OPC) $4,552,647 $4,552,647 $4,366,265 96%
MR 1st and 2nd dose (NVS) $54,500 $54,500
MR 1st dose (NVS) $1,135,000 $2,142,500
MR-Catch-up campaign (NVS) $13,216,000 $13,216,000
MR-Catch-up campaign op.costs (OPC) $11,181,873 $11,181,873
Operational costs (OPC) $349,355 $349,355 $349,355 100%
Penta (NVS) $173,257,366 $176,236,366 $171,714,069 99%
Penta - campaign (NVS) $765,000 $765,000
Pneumo (NVS) $113,625,497 $128,725,497 $100,419,887 88%
Pneumo - campaign (NVS) $3,287,000 $3,287,000
Product Switch Grant (PSG) $470,533 $470,533
Rotavirus (NVS) $12,562,000 $20,374,000 $8,440,749 67%
Vaccine Introduction Grant (VIG) $7,224,260 $7,224,260 $5,672,000 79%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Uganda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 94%
M:F sex ratio at birth (2018) 1.03
Household survey: DTP3 coverage for male (2010) 72.00%
Household survey: DTP3 coverage for female (2010) 71.00%
Household survey: Last DTP3 survey (2010) 72%
% districts achieving > 80% DTP3 coverage (2017) 84%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 80%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$40,557,711 $312,094,625

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Uganda

12 December 2018

MTR HE Reem Al Hashimy

Global health leaders hail immunisation as shortest path to healthy lives

Gavi Mid-Term Review closes with commitments to accelerate immunisation programmes in the poorest countries to reach more children with lifesaving vaccines.

10 December 2018

Gavi item

Parsyl and Gavi announce supply chain strengthening partnership

Gavi to make Parsyl’s quality assurance platform available in Uganda and Senegal to address last mile distribution challenge.

04 December 2018

Gavi, UPS and FIT in Uganda

Mobile phones and digital technology to boost vaccine delivery in Uganda

New collaboration will address vaccine supply challenges in 171 health facilities ensuring that children in the hardest-to-reach areas are protected with vaccines.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here